Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisa Menicali

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Frontiers in Endocrinology|May 14, 2021
Immune Landscape of Thyroid Cancers: New InsightsElisa Menicali, Martina Guzzetti, Silvia Morelli, et al.
Endocrine|November 6, 2015
Timing of breakfast does not influence therapeutic efficacy of liquid levothyroxine formulationSilvia Morelli, Gianpaolo Reboldi, Sonia Moretti, et al.
European Journal of Endocrinology|May 26, 2020
THERAPY OF ENDOCRINE DISEASE Immunotherapy of advanced thyroid cancer: from bench to bedsideSonia Moretti, Elisa Menicali, Nicole Nucci, et al.
Frontiers in Endocrinology|June 5, 2012
Intracellular signal transduction and modification of the tumor microenvironment induced by RET/PTCs in papillary thyroid carcinomaElisa Menicali, Sonia Moretti, Pasquale Voce, et al.
Cancers|January 16, 2020
The Aryl Hydrocarbon Receptor Is Expressed in Thyroid Carcinoma and Appears to Mediate Epithelial-Mesenchymal-TransitionSonia Moretti, Nicole Nucci, Elisa Menicali, et al.
The Journal of Clinical Endocrinology and Metabolism|September 27, 2024
Wnt/B-catenin Activation and TP53 Mutations Associate With Distinct Immune Profiles in Advanced Thyroid CancerSonia Moretti, Martina Mandarano, Elisa Menicali, et al.
The Journal of Biological Chemistry|December 21, 2016
Signal Transducer and Activator of Transcription 1 Plays a Pivotal Role in RET/PTC3 Oncogene-induced Expression of Indoleamine 2,3-Dioxygenase 1Sonia Moretti, Elisa Menicali, Nicole Nucci, et al.
The Journal of Clinical Endocrinology and Metabolism|March 19, 2019
Immune Profiling of Thyroid Carcinomas Suggests the Existence of Two Major Phenotypes: An ATC-Like and a PDTC-LikeRiccardo Giannini, Sonia Moretti, Clara Ugolini, et al.
The Journal of Clinical Endocrinology and Metabolism|February 13, 2014
Indoleamine 2,3-dioxygenase 1 (IDO1) is up-regulated in thyroid carcinoma and drives the development of an immunosuppressant tumor microenvironmentSonia Moretti, Elisa Menicali, Pasquale Voce, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Frontiers in Endocrinology|May 14, 2021
Immune Landscape of Thyroid Cancers: New InsightsElisa Menicali, Martina Guzzetti, Silvia Morelli, et al.
Endocrine|November 6, 2015
Timing of breakfast does not influence therapeutic efficacy of liquid levothyroxine formulationSilvia Morelli, Gianpaolo Reboldi, Sonia Moretti, et al.
European Journal of Endocrinology|May 26, 2020
THERAPY OF ENDOCRINE DISEASE Immunotherapy of advanced thyroid cancer: from bench to bedsideSonia Moretti, Elisa Menicali, Nicole Nucci, et al.
Frontiers in Endocrinology|June 5, 2012
Intracellular signal transduction and modification of the tumor microenvironment induced by RET/PTCs in papillary thyroid carcinomaElisa Menicali, Sonia Moretti, Pasquale Voce, et al.
Cancers|January 16, 2020
The Aryl Hydrocarbon Receptor Is Expressed in Thyroid Carcinoma and Appears to Mediate Epithelial-Mesenchymal-TransitionSonia Moretti, Nicole Nucci, Elisa Menicali, et al.
The Journal of Clinical Endocrinology and Metabolism|September 27, 2024
Wnt/B-catenin Activation and TP53 Mutations Associate With Distinct Immune Profiles in Advanced Thyroid CancerSonia Moretti, Martina Mandarano, Elisa Menicali, et al.
The Journal of Biological Chemistry|December 21, 2016
Signal Transducer and Activator of Transcription 1 Plays a Pivotal Role in RET/PTC3 Oncogene-induced Expression of Indoleamine 2,3-Dioxygenase 1Sonia Moretti, Elisa Menicali, Nicole Nucci, et al.
The Journal of Clinical Endocrinology and Metabolism|March 19, 2019
Immune Profiling of Thyroid Carcinomas Suggests the Existence of Two Major Phenotypes: An ATC-Like and a PDTC-LikeRiccardo Giannini, Sonia Moretti, Clara Ugolini, et al.
The Journal of Clinical Endocrinology and Metabolism|February 13, 2014
Indoleamine 2,3-dioxygenase 1 (IDO1) is up-regulated in thyroid carcinoma and drives the development of an immunosuppressant tumor microenvironmentSonia Moretti, Elisa Menicali, Pasquale Voce, et al.
Pageof 1